Clincosm LogoSign in Get a demo

uc (urothelial cancer)

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Solid Tumors, Colorectal Cancer (CRC) Trial in Worldwide (INCB001158, Pembrolizumab)

Active, not recruiting
Has Results
  • Metastatic Cancer
  • +9 more
  • Mobile, Alabama
  • +19 more
Aug 1, 2022

Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)

Completed
  • Colorectal Cancer (CRC)
  • +10 more
  • San Francisco, California
  • +16 more
Mar 30, 2022

UC (Urothelial Cancer) Trial in Worldwide (pemigatinib)

Completed
  • UC (Urothelial Cancer)
  • Tucson, Arizona
  • +95 more
Feb 28, 2022

Solid Tumors, Head Neck Cancer, Lung Cancer Trial in United States (MEDI4736, INCB024360)

Completed
Has Results
  • Solid Tumors
  • +3 more
  • San Francisco, California
  • +12 more
Jan 7, 2022

UC (Urothelial Cancer) Trial in Worldwide (Pembrolizumab, Epacadostat, Placebo)

Completed
Has Results
  • UC (Urothelial Cancer)
  • Tucson, Arizona
  • +142 more
Nov 17, 2021

NSCLC (Non-small Cell Lung Carcinoma), UC (Urothelial Cancer) Trial in United States (atezolizumab, epacadostat)

Terminated
  • NSCLC (Non-small Cell Lung Carcinoma)
  • UC (Urothelial Cancer)
  • Scottsdale, Arizona
  • +5 more
Dec 7, 2017